Delivery Order SPE2DB22D2206-SPE2DB25FGS74
- Not listed
- The Defense Logistics Agency awarded a $17,181.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of OFEV 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. This non-set-aside competitive award was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $9,053.16 to AmerisourceBergen Drug Corp for 60 capsules of OFEV 150 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. This firm fixed-price delivery order, issued on December 19, 2025, with an ultimate completion date of January 13, 2026, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,094.99 for OFEV 100 mg capsules (60-count units) on December 10, 2025, with an ultimate completion date of January 2, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open procurement process. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OFEV (pirfenidone) 100 mg capsules, 60-count packages, valued at $17,260.58 under a firm fixed-price contract type. This award, issued on July 31, 2025, represents a non-competitive delivery order for pharmaceutical supply with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $9,053.16 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 150 mg, a pharmaceutical product for pulmonary fibrosis treatment. The contract employs firm fixed pricing with an ultimate completion date of January 12, 2026, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $17,260.58 delivery order to AmerisourceBergen Drug Corp for 60 capsules of Ofev 100 mg, a pharmaceutical product used in the treatment of idiopathic pulmonary fibrosis. The contract was competitively awarded without set-aside provisions on September 24, 2025, with an ultimate completion date of October 16, 2025. This delivery order operates under a firm fixed-price arrangement and is performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) under a firm fixed price arrangement. The award was made on September 17, 2025, with an ultimate completion date of October 8, 2025. This is a non-set-aside competitive award, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for OFEV 150 mg capsules (60-count units) on June 18, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that serves as...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for 60 capsules of OFEV 150 mg on September 25, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,630.28 to AmerisourceBergen Drug Corp for OFEV 100 mg capsules (60-count units) on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGS74Delivery Order
The Defense Logistics Agency awarded a $34,362.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 capsules of OFEV 150 mg, a pharmaceutical product used primarily to treat idiopathic pulmonary fibrosis. The contract, awarded on April 24, 2025, with an ultimate completion date of May 15, 2025, was not set-aside and represents a competitive award. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive vehicle for pharmaceutical and medical supply procurement supporting military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for defense and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency covering a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a competitively awarded vendor, AmerisourceBergen demonstrates capability to fulfill federal medical supply requirements and serves customers including the Defense Health Agency and U.S. Coast Guard through flexible contract vehicles designed to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.4k | 4/24/25 |